ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

CMRX Chimerix Inc

0.9504
-0.0596 (-5.90%)
May 10 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 126,065
Bid Price 0.9503
Ask Price 1.05
News -
Day High 1.03

Low
0.88

52 Week Range

High
1.57

Day Low 0.96
Company Name Stock Ticker Symbol Market Type
Chimerix Inc CMRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0596 -5.90% 0.9504 18:34:52
Open Price Low Price High Price Close Price Prev Close
1.03 0.96 1.03 0.9705 1.01
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
652 126,065 $ 0.9864193 $ 124,353 - 0.88 - 1.57
Last Trade Time Type Quantity Stock Price Currency
19:53:24 2 $ 0.97 USD

Chimerix Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
85.64M 89.21M - 324k -82.1M -0.92 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Chimerix News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CMRX Message Board. Create One! See More Posts on CMRX Message Board See More Message Board Posts

Historical CMRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.981.040.93740.9921477247,718-0.0296-3.02%
1 Month1.011.040.880.936438279,814-0.0596-5.90%
3 Months1.051.300.881.06388,344-0.0996-9.49%
6 Months0.941.300.881.01384,8300.01041.11%
1 Year1.121.570.881.13627,492-0.1696-15.14%
3 Years8.169.28990.882.851,346,317-7.21-88.35%
5 Years2.8511.56960.883.211,069,601-1.90-66.65%

Chimerix Description

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment namely pharmaceuticals.

Your Recent History

Delayed Upgrade Clock